HollisterStier Allergy
hollisterStier Icon

Venom Immunotherapy

The red imported fire ant (Solenopsis invicta), once native only to parts of South America1 and historically contained to the southeastern United States, is on the move. Rising temperatures, increased rainfall, and soil transport through landscaping and agriculture have allowed this aggressive species to expand far beyond its original range. For allergy specialists, this migration signals more than an ecological concern, it is an emerging medical threat that demands attention.

As fire ants spread into new territories, they bring potent venom with them capable of inducing severe allergic reactions in a population who has never encountered fire ants before. Allergists across the country must prepare for this shifting landscape by understanding the clinical risks and ensuring their patients are protected.

WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroiddependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

Fire Ant Expansion: Where Are They Going?

The red imported fire ant was first introduced in the US via Mobile, Alabama in the 1930’s, likely through cargo shipments. Since then, fire ants have established themselves across much of the South, thriving in warm, moist environments.

However, recent climate data and ecological studies show that fire ants are expanding northward and westward. Research from the USDA Agricultural Research Service estimates that fire ants could spread into larger portions of the Mid-Atlantic, the lower Midwest, the Southwest, and even parts of California, Arizona, and Oregon if warming trends continue.2

This means that areas previously considered safe from fire ant infestations are now seeing reports of colonies and stings.3 For allergists in these states, fire ant sensitization and anaphylaxis are becoming a new clinical reality.

Fire Ant Venom as a Potent Allergen

Unlike bees and wasps, fire ants sting multiple times in quick succession and inject venom with each sting. The venom contains a mixture of alkaloids and protein allergens that can trigger robust allergic responses in sensitized individuals.4

While most people experience localized pain, swelling, pustule formation, a significant subset may develop systemic reactions. These reactions range from generalized hives and angioedema to full-blown anaphylaxis with hypotension, airway compromise, and cardiovascular collapse.

Studies show that up to 20% of fire ant stings result in large local reactions, and approximately 0.5% – 2% of stung individuals may experience systemic allergic reactions. In highly colonized regions, 8.5% – 51% of residents may be stung each year, putting a sizable population at risk.5

The Clinical Impact of Fire Ant Allergies

With fire ants spreading to new states, allergists must now consider fire ant allergy in patients presenting with systemic reactions to insect stings in general, especially in areas where fire ants were previously non-endemic.

Diagnosis

  • Skin testing for Solenopsis invicta venom is a primary tool for diagnosing fire ant allergies.
  • Skin testing results in the most specific diagnosis of fire ant allergies by utilizing IgE detection.6

Risk Stratification

  • Patients with prior systemic reactions, outdoor workers, children, and the elderly are at risk of severe reactions to fire ant venom.
  • Those with multiple exposures such as landscapers, gardeners, and construction workers may become sensitized over time.

Patient Education

  • Patients should be taught how to recognize the signs of anaphylaxis and learn their options for treatment, such as allergy immunotherapy.
  • Avoidance strategies should be emphasized, especially in newly infested regions.
Woman suffering from allergies inside of an office.

Immunotherapy for Fire Ant Allergies

Allergy immunotherapy for fire ant venom is highly effective in preventing systemic reactions at a similar rate to venom immunotherapy for flying Hymenoptera venom.7

Key Facts

  • Fire ant VIT uses whole-body extract of Solenopsis invicta to produce the extract.
  • The standards course includes build-up injections followed by maintenance injections typically given every 4 weeks.
  • Patients often remain in the maintenance phase of immunotherapy for 3 to 5 years.
  • Even though skin test often remain positive, clinical protection is maintained long after desensitization.7

Why Trust HollisterStier Allergy?

When it comes to venom immunotherapy, product quality and reliability matter. HollisterStier Allergy is a leading US manufacturer of FDA-approved allergenic extracts, including those used for fire ant venom immunotherapy.

Why Choose HS Allergy?

  • High-quality extracts manufactured to rigorous standards for purity and potency.
  • Consitency and reliability ensures each vial provides reproducible clinical performance.
  • Responsive customer support with a dedicated team that understands the needs of allergists.
  • Secure supply chain where we harvest and produce our extracts in house, minimizing disruptions, even during periods of increased demand.

As fire ant migration introduces venom allergy risk to new patient populations, having a dependable source of fire ant extract is crucial. Protect your patients with HollisterStier Allergy, no matter where fire ants move next.

Prepare Your Practice for Fire Ants

As ecological patterns change and insect species migrate, allergists must adapt. Fire ant allergies are no longer region specific, the clinical burden is shifting to allergists in new states and regions and will continue to do so as climate change progresses.

Here’s what you can do to best support your patients:

 

  • Stay informed by monitoring entomological data and reports of fire ant spread in your region.
  • Educate your team by training staff to recognize symptoms and risk factors for fire ant allergy.
  • Stock the right extracts by ordering Solenopsis invicta venom immunotherapy from a trusted source like HollisterStier Allergy.
  • Engage with your community and raise awareness with patients within your community about the rising risks of fire ant allergies.

 

The expansion of fire ants across the US is no longer a hypothetical, it’s happening now. With that expansion comes increased allergic risk, more anaphylactic events, and a need for proactive treatment planning.

Allergists must lead the response. By diagnosing early, educating patients, and administering effective immunotherapy using reliable extracts, we can dramatically reduce the burden of fire ant venom allergy.

Article References

  1. “Red Imported Fire Ant.” Center for Invasive Species Research, cisr.ucr.edu/invasive-species/red-imported-fire-ant.
  2. “Potential United States Range Expansion of the Invasive Fire Ant : USDA ARS.” gov, 2017, www.ars.usda.gov/southeast-area/gainesville-fl/cmave/imported-fire-ant-and-household-insects-research/docs/potential-united-states-range-expansion-of-the-invasive-fire-ant/.
  3. “Antmaps.org.” org, 2020, antmaps.org/?
  4. Zamith-Miranda, Daniel, et al. “The Allergic Response Mediated by Fire Ant Venom Proteins.” Scientific Reports, vol. 8, no. 1, 26 Sept. 2018, p. 14427, www.nature.com/articles/s41598-018-32327-z, https://doi.org/10.1038/s41598-018-32327-z. Accessed 29 Sept. 2023.
  5. Lopez, Diego J., et al. “The Human Health Impacts of the Red Imported Fire Ant in the Western Pacific Region Context: A Narrative Review.” Tropical Medicine and Infectious Disease, vol. 9, no. 4, 1 Apr. 2024, p. 69, www.mdpi.com/2414-6366/9/4/69#:~:text=Around%2025%25%20of%20those%20stung, https://doi.org/10.3390/tropicalmed9040069.
  6. Kruse, Brian, et al. “Fire Ant Bites.” PubMed, StatPearls Publishing, 2021, www.ncbi.nlm.nih.gov/books/NBK470576/.
  7. Neaves, Brittanie I, and Christopher A Coop. “Imported Fire Ant Immunotherapy.” Annals of Allergy Asthma & Immunology, vol. 133, no. 1, 26 Jan. 2024, pp. 28–32, https://doi.org/10.1016/j.anai.2024.01.014.

                                  Venom Immunotherapy

                                  Allergies are a growing public health concern as climate change impacts the start and length of allergy season, along with an increase in allergies among recent generations. However, not all individuals are affected equally. Research increasingly shows that social determinants of health, such as poverty, race, and access to healthcare, play a role in shaping allergy prevalence, diagnosis, and treatment outcomes. This article explores how these factors intersect with allergies and highlights the need for equitable solutions to address disparities in allergy care.

                                  WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                  Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroiddependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                  The Link Between Poverty and Allergies

                                  Poverty is a powerful determinant of health, influencing everything from environmental exposures to access to adequate medical care. For people living in low-income communities, the risk of developing allergies is often heightened due to a combination of environmental, nutritional, and psychological factors.

                                  Environmental Exposures in Low-Income Communities

                                  Substandard housing conditions, which are more common in low-income areas, can increase exposure to allergens such as mold, dust mites, and cockroaches. These allergens are known triggers for asthma and other allergic conditions for both adults and children, and sometimes pets.

                                  Households located in low-income areas have been linked to increased allergen exposure and sensitization, along with higher levels of asthma morbidity and mortality for children. Substandard housing can also be a prime breeding ground for mites, cockroaches, and mold due to excess moisture from lack of proper ventilation. Water leaks, exposure to endotoxins, and inadequate pest control create environments where allergies thrive. It is also common for low-income neighborhoods to be located near areas of large vehicle traffic, which can increase ambient particular matter and fuel fumes, exacerbating allergy and asthma symptoms.1

                                  Woman suffering from allergies inside of an office.

                                  Nutritional Factors

                                  Access to nutritious, diversified food is another critical factor influencing allergy risk. Low-income communities often face food insecurity, with limited access to fresh fruits, vegetables, and other foods that support immune health. A diet high in processed foods and low in essential nutrients can weaken the immune system, making individuals more susceptible to allergies and immune dysfunction.2,3

                                  Stress and Immune Function

                                  Chronic stress, which is more prevalent in low-income populations4, can also contribute to allergic conditions. Stress has been shown to dysregulate the immune system, increasing inflammation and worsening conditions like asthma and eczema. It also plays a significant role in manifesting and treating allergic disease.5 This highlights the need for holistic approaches to allergy management that address both psychological and environmental factors.

                                  Racial Disparities in Allergy Prevalence and Treatment

                                  Racial and ethnic minorities often face a disproportionate burden of allergic conditions, driven by a combination of genetic, environmental, and systemic factors. Understanding these disparities is essential for developing targeted interventions.

                                  Higher Prevalence of Allergies in Certain Minority Groups

                                  Research has shown that certain populations experience higher rates of asthma and food allergies compared to others. For example, some studies indicate that children from specific economic and racial back grounds are more likely to develop allergies, including food allergies. In a study conducted in 2020, Black children were found to have higher odds of allergies to shellfish and finfish, along with higher rates of asthma than White children from similar backgrounds.6 Higher prevalence of asthma has also been found in populations below the poverty threshold, along with more self-reported food allergies in ethnic minority groups.7 There has also been an increase in food allergies across the board, with a greater increase in allergies for non-Hispanic Black children.8

                                  Barriers to Accessing Allergy Care

                                  Access to healthcare is a major barrier for many racial and ethnic minorities and low-income individuals. Lack of insurance, transportation, and culturally competent care can prevent individuals from receiving timely and effective allergy care and treatment. Racial and ethnic minorities are less likely to receive appropriate allergy care in emergency departments, leading to worse outcomes. Children from racial and ethnic minority groups were found to have higher odds of steroid administration, a short-term treatment option that can cause both short-term and long-term side effects , and lower odds of radiological testing, used to assess for issues that mimic allergy symptoms, after being admitted to the ER compared to White children.9

                                  These barriers compounded with systemic inequalities created by redlining and predatory lending that constrained minority populations to neighborhoods with poor housing conditions, resulted in higher levels of respiratory issues, asthma, and other allergies in low-income patients. These low-income patients are then less likely to be prescribed biologics to treat their allergies compared to those in higher income communities due to high cost, reduced access to subspecialists, and offer rates from providers.10

                                  Implicit Bias in Healthcare

                                  Implicit bias among healthcare providers can also contribute to disparities in allergy care. After compiling and analyzing 28 studies on implicit bias in the healthcare industry, researchers found evidence that minority patients are often undertreated or misdiagnosed due to unconscious biases. These unconscious biases can also negatively impact patient-provider interactions and treatment decisions. A specific example is that Black patients in the US are significantly more likely to be questioned about smoking than White patients. In four other studies, researchers found a significant correlation between high levels of pro-White implicit bias and treatment responses that favored those patients.11

                                  Addressing implicit bias through training and education is essential for ensuring equitable care for all patients, no matter their background.12

                                  The Role of Urban vs. Rural Settings

                                  Where individuals live can also influence their allergy risk and access to care. Urban and rural environments present unique challenges that must be addressed to reduce disparities.

                                  Urban Environments and Allergy Triggers

                                  Urban areas, particularly low-income neighborhoods, are often hotspots for environmental allergens. Air pollution, traffic-related emissions, and high levels of indoor allergens are common in these settings. Urban air pollution exacerbates respiratory allergies and asthma, particularly in children. Addressing these environmental triggers requires targeted policies, such as improving housing quality and reducing air pollution.13

                                  Rural vs. Urban Access to Allergy Specialists

                                  While urban areas may have higher levels of environmental allergens, rural areas often face a shortage of healthcare providers, including allergists. This lack of access to specialized care can delay diagnosis and treatment, preventing individuals from receiving the care they need. Children in rural areas are less likely to receive a timely, accurate diagnosis of food allergies compared to their urban counterparts. Expanding telehealth services and increasing the number of allergists in rural areas are potential solutions to this problem.14

                                  Solutions and Policy Implications

                                  Addressing the impact of poverty and race on allergies requires a multifaceted approach that includes policy changes, community-based interventions, and efforts to improve cultural competence in healthcare.

                                  When discussing how to limit the impact of allergies on low-income and minority communities, it’s important to address the social determinants of health through policy changes that promote health equity. In a study conducted by two contributors at the Henry J. Kaiser Family Foundation, researchers found that by ensuring individuals have access to affordable, high-quality healthcare, disparities between populations can be reduced significantly.15

                                  Community health initiatives that address housing quality, nutrition, and education about allergies and health management can also make a difference. Community-based asthma interventions have effectively reduced hospitalizations and improved the quality of life for children in low-income communities. Similar programs could be developed to assist other allergic conditions, such as food allergies and eczema.16

                                  Lastly, training healthcare providers to recognize and confront racial and socioeconomic biases, while addressing disparities, is essential for ensuring equitable treatment. By fostering a healthcare system that is inclusive and responsive to the needs of all patients, we can create a more equitable future for allergy care.17

                                  While the link between socioeconomic factors and allergy disparities is well-documented, many studies are qualitative, resulting in a notable gap in large-scale quantitative studies that measure how these variables impact allergy outcomes. A review published in 2019 highlights that much of the existing research relies on small cohorts or observational data due to a lack of comprehensive and conclusive research conducted on minority and low-income populations. As presented in this review, while Black and Latino populations make up 30% of the US population, they account for only 6% of all participants in federally funded clinical trials. This same study found that only 2% of government-funded cancer research has focused on minority health needs, and even though Black Americans are one-third more likely to have asthma and over three times more likely to die from complications compared to White Americans, only 5% of federally funded lung disease studies over the past 20 years have been focused on minority groups.18 This underscores the need for more awareness and understanding of these issues to support equitable care across all populations.

                                  Socioeconomic and racial affiliation are powerful determinants of health that significantly impact allergy prevalence and treatment outcomes. From environmental exposures in low-income housing to systemic barriers in healthcare access, these factors create disparities that must be deal with through target interventions and policy changes. By raising awareness of these issues and advocating for equitable solutions, we can work toward a future where everyone has the opportunity to live a healthy, allergy-free life.

                                  Article References

                                  1. Pacheco, Christina M., et al. “Homes of Low-Income Minority Families with Asthmatic Children Have Increased Condition Issues.” Allergy and Asthma Proceedings, vol. 35, no. 6, 1 Nov. 2014, pp. 467–474, www.ncbi.nlm.nih.gov/pmc/articles/PMC4210655/, https://doi.org/10.2500/aap.2014.35.3792.
                                  2. Treffeisen, Elsa R., et al. “The Association between Child Food Allergy and Family Food Insecurity in a Nationally Representative US Sample.” Academic Pediatrics, Aug. 2024, https://doi.org/10.1016/j.acap.2024.08.010.
                                  3. Gowda, Charitha, et al. “The Association between Food Insecurity and Inflammation in the US Adult Population.” American Journal of Public Health, vol. 102, no. 8, 1 Aug. 2012, pp. 1579–1586, www.ncbi.nlm.nih.gov/pmc/articles/PMC3464824/, https://doi.org/10.2105/AJPH.2011.300551. Accessed 11 Mar. 2021.
                                  4. Kaplan, Sue A., et al. “The Perception of Stress and Its Impact on Health in Poor Communities.” Journal of Community Health, vol. 38, no. 1, 18 July 2012, pp. 142–149, https://doi.org/10.1007/s10900-012-9593-5.
                                  5. Dave, Ninabahen D., et al. “Stress and Allergic Diseases.” Immunology and Allergy Clinics of North America, vol. 31, no. 1, Feb. 2011, pp. 55–68, www.ncbi.nlm.nih.gov/pmc/articles/PMC3264048/, https://doi.org/10.1016/j.iac.2010.09.009.
                                  6. Mahdavinia, Mahboobeh, et al. “African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study.” The Journal of Allergy and Clinical Immunology: In Practice, Jan. 2021, https://doi.org/10.1016/j.jaip.2020.12.026. 
                                  7. Jones, Christina J., et al. “Burden of Allergic Disease among Ethnic Minority Groups in High‐Income Countries.” Clinical & Experimental Allergy, vol. 52, no. 5, 14 Apr. 2022, pp. 604–615, https://doi.org/10.1111/cea.14131. 
                                  8. Keet, Corinne A., et al. “Temporal Trends and Racial/Ethnic Disparity in Self-Reported Pediatric Food Allergy in the United States.” Annals of Allergy, Asthma & Immunology, vol. 112, no. 3, Mar. 2014, pp. 222-229.e3, https://doi.org/10.1016/j.anai.2013.12.007. Accessed 21 Sept. 2019. 
                                  9. Zook, Heather G., et al. “Racial/Ethnic Variation in Emergency Department Care for Children with Asthma.” Pediatric Emergency Care, vol. 35, no. 3, Mar. 2019, pp. 209–215, https://doi.org/10.1097/pec.0000000000001282. Accessed 27 Oct. 2019. 
                                  10. Udemgba, Chioma, et al. “New Considerations of Health Disparities within Allergy and Immunology.” Journal of Allergy and Clinical Immunology, vol. 151, no. 2, 1 Feb. 2023, pp. 314–323, www.jacionline.org/article/S0091-6749(22)01516-0/fulltext, https://doi.org/10.1016/j.jaci.2022.11.004. Accessed 4 Mar. 2023. 
                                  11. FitzGerald, Chloë, and Samia Hurst. “Implicit Bias in Healthcare Professionals: A Systematic Review.” BMC Medical Ethics, vol. 18, no. 1, 1 Mar. 2017, bmcmedethics.biomedcentral.com/articles/10.1186/s12910-017-0179-8, https://doi.org/10.1186/s12910-017-0179-8. 
                                  12. Fricke, Julie, et al. “Healthcare Worker Implicit Bias Training and Education: Rapid Review.” PubMed, Agency for Healthcare Research and Quality (US), 2023, www.ncbi.nlm.nih.gov/books/NBK600156/. 
                                  13. D’amato, G, et al. “Urban Air Pollution and Climate Change as Environmental Risk Factors of Respiratory Allergy: An Update.” J Investig Allergol Clin Immunol, vol. 20, no. 2, 2010, pp. 95–102, www.jiaci.org/issues/vol20issue2/1.pdf?module=inline&pgtype=article. 
                                  14. Pongdee, Thanai, et al. “Rural Health Disparities in Allergy, Asthma, and Immunologic Diseases: The Current State and Future Direction for Clinical Care and Research.” The Journal of Allergy and Clinical Immunology: In Practice, vol. 12, no. 2, 1 Feb. 2024, pp. 334–344, www.sciencedirect.com/science/article/pii/S2213219823012990, https://doi.org/10.1016/j.jaip.2023.11.030. Accessed 25 Feb. 2024. 
                                  15. Artiga, Samantha, and Elizabeth Hinton. Beyond Health Care: The Role of Social Determina.nts in Promoting Health and Health Equity . 2018 
                                  16. Chan, Mei, et al. “Community-Based Interventions for Childhood Asthma Using Comprehensive Approaches: A Systematic Review and Meta-Analysis.” Allergy, Asthma & Clinical Immunology, vol. 17, no. 1, 15 Feb. 2021, aacijournal.biomedcentral.com/articles/10.1186/s13223-021-00522-9, https://doi.org/10.1186/s13223-021-00522-9. 
                                  17. Bd, Smedley, et al. “Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.” PubMed, 2003, pubmed.ncbi.nlm.nih.gov/25032386/.
                                  18. Konkel, Lindsey. “Racial and Ethnic Disparities in Research Studies: The Challenge of Creating More Diverse Cohorts.” Environmental Health Perspectives, vol. 123, no. 12, Dec. 2015, www.ncbi.nlm.nih.gov/pmc/articles/PMC4670264/, https://doi.org/10.1289/ehp.123-a297. Accessed 3 Dec. 2019.

                                                                  Venom Immunotherapy

                                                                  From seasonal allergies to food sensitivities, the impact of allergic reactions can range from mild discomfort to life-threatening anaphylaxis. Accurate diagnosis is the cornerstone of effective allergy treatment and skin testing remains one of the most reliable and widely used diagnostic tools. This article explores the importance of skin testing in allergy treatment, its benefits, and how it compares to other diagnostic methods.

                                                                  WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                  Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroiddependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                  What is Skin Testing?

                                                                  Skin testing is a diagnostic procedure used to identify specific allergens that might trigger an allergic reaction in an individual. The test procedure involves exposing the skin to small amounts of suspected allergens and observing the reaction. There are two primary types of skin tests:

                                                                  1. Skin Prick Test (SPT), also known as puncture or scratch tests: This is the most common form of skin testing. A small amount of allergen extract is placed on the skin, usually on the forearm or back, and then a tiny needle prick is made through the drop to allow the allergen to enter the skin. If the person is allergic, a small, raised bump (wheal) surrounded by redness (flare) will appear within 15 to 20 minutes. The ComforTen® and QuinTip® Skin Test Devices provided by HollisterStier Allergy are designed to encourage uniform skin testing results and allow readings of 3mm+ to read positive during an allergy test.1 These two devices are also self-loading, innovating the traditional testing process by removing the need to place the extract directly on the skin.

                                                                  2. Intradermal Test: This test involves injecting a small amount of allergen extract just beneath the skin’s surface. It is more sensitive than the skin prick test and is often used when the skin prick test results are inconclusive.

                                                                  Why is Skin Testing Important?

                                                                  Accurate Diagnosis

                                                                  Skin testing is considered the gold standard for diagnosing allergic conditions. Skin tests are highly sensitive and specific, making them an invaluable tool for identifying the exact allergens responsible for a patient’s symptoms.2 Accurate diagnosis informs the development of an effective treatment plan, which may include allergen avoidance, medication, or immunotherapy.
                                                                  Woman suffering from allergies inside of an office.

                                                                  Personalized Treatment Plans

                                                                  Once the specific allergens are identified through skin testing, healthcare providers can tailor treatment plans based on the individual needs of the patient. If a patient is allergic to pollen, they may be advised to stay indoors during high pollen counts, use air purifiers, and take antihistamines. In cases of severe allergies, allergen immunotherapy (or allergy shots) may be recommended to desensitize the immune system to the allergen over time.3

                                                                  Early Detection and Prevention

                                                                  Early detection of allergies through skin testing can prevent the progression of allergic diseases. For instance, children with allergic rhinitis are at a higher risk of developing asthma, so catching symptoms early might prevent development of comorbid conditions. Identifying and managing allergies early can reduce this risk and improve long-term outcomes.4

                                                                  Differentiating Between Allergies and Other Conditions

                                                                  Allergic symptoms can often mimic other conditions, such as infections or autoimmune diseases. Skin testing helps differentiate between these conditions, ensuring that patients receive the appropriate treatment. Skin testing can help determine if allergies are a contributing factor to other conditions, as well.5

                                                                  Monitoring Treatment Efficacy

                                                                  Skin testing is not only useful for initial diagnosis but also for monitoring the effectiveness of prescribed allergy treatments. For patients undergoing allergen immunotherapy, repeat skin testing can show a reduction in skin reactivity to allergens, indicating that the treatment is working.6

                                                                  Benefits of Skin Testing Over Other Diagnostic Methods

                                                                  While there are other methods for diagnosing allergies, such as blood tests (IgE tests), skin testing offers several advantages:

                                                                  Speed and Convenience

                                                                  Skin testing provides immediate results, usually within 15 to 20 minutes. This allows for quick diagnosis and the ability to discuss treatment options during the same visit. In contrast, blood tests require sending samples to a lab, and results may take several days.7

                                                                  Cost Effectiveness

                                                                  Skin testing is generally more cost-effective than blood tests. It requires fewer resources and can be performed in a single office visit, making it more affordable option for many patients.8

                                                                  Higher Sensitivity and Specificity

                                                                  Skin tests are more sensitive and specific than blood tests, especially for airborne allergens like pollen, dust mites, and pet dander. This makes skin testing the preferred method for diagnosing respriatory allergies.9

                                                                  Patient Engagement

                                                                  Skin testing allows patients to see and understand their allergic reactions in real-time. This visual feedback can be motivating and help patients adhere to their treatment plans. Patients are able to ask questions about their allergies during the same office visit. It also provides an opportunity for healthcare providers to educate patients about their allergies and how to manage them effectively.10

                                                                  Limitations and Considerations

                                                                  While skin testing is highly effective, it is not without limitations. Some of these potential limitations include:

                                                                  1. Medication Interference: Certain medications, such as antihistamines, can interfere with skin test results. Patients may need to stop taking these medications for a few days before the test to ensure accruate results.3

                                                                  2. Skin Conditions: Patients with severe eczema or other skin conditions may not be suitable candidates for skin testing. In such cases, blood tests may be a better alternative.5

                                                                  3. Risk of Severe Reactions: Although rare, there is a small risk of severe allergic reactions during skin testing. This is why skin tests should always be performed under the supervision of a trained healthcare provider who can manage any adverse reactions.2

                                                                  Skin testing is an important tool when it comes to the diagnosis and management of allergies. Its accuracy, speed, and cost-effectiveness make it the preferred method for identifying specific allergens and developing personalized treatment plans. While it has some limitations, the benefits of skin testing far outweigh the drawbacks, making it an indispensable part of allergy care.

                                                                  When utilizing innovative tools like the ComforTen® and QuinTip® Skin Test Devices, healthcare providers can achieve better health outcomes and improve the quality of life for those affected by allergies. Request a quote today to learn more about how HollisterStier Allergy elevates allergy care.

                                                                  Article References

                                                                  1. Nelson, H.S., et al. “Evaluation of Devices for Skin Prick Testing” J. Allergy Clin. Immunol.; 101: 153-156. February 1998.
                                                                  2. American Academy of Allergy, Asthma & Immunology (AAAAI). (2023). Allergy Testing. Retrieved from https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/allergy-testing 
                                                                  3. Cleveland Clinic. (2023). Allergy Testing. Retrieved from https://my.clevelandclinic.org/health/diagnostics/21495-allergy-testing 
                                                                  4. World Allergy Organization Journal. (2019). Early Detection of Allergies. Retrieved from https://www.worldallergyorganizationjournal.org/article/S1939-4551(19)31236-0/fulltext 
                                                                  5. Mayo Clinic. (2023). Allergy Tests. Retrieved from https://www.mayoclinic.org/tests-procedures/allergy-tests/about/pac-20392895 
                                                                  6. Annals of Allergy, Asthma & Immunology. (2022). Monitoring Treatment Efficacy. Retrieved from https://www.annallergy.org/article/S1081-1206(22)01832-4/fulltext 
                                                                  7. AACI Journal. (2020). Advances in Allergy Testing. Retrieved from https://aaciijournal.biomedcentral.com/articles/10.1186/s13223-020-00461-x 
                                                                  8. PMC. (2013). Cost-Effectiveness of Allergy Testing. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555364 
                                                                  9. ScienceDirect. (2024). Sensitivity and Specificity of Skin Testing. Retrieved from https://www.sciencedirect.com/science/article/pii/S1081120624000012 
                                                                  10. American Academy of Family Physicians (AAFP). (2018). Allergy Testing in Primary Care. Retrieved from https://www.aafp.org/pubs/afp/issues/2018/0701/p24.html 

                                                                  Venom Immunotherapy
                                                                  Allergies are a universal health issue that affects millions of people worldwide. However, for those living in the United States, there has been a rumor that allergies are worse in the US than in other countries.1 From rising pollen levels to dietary habits and access to healthcare, multiple factors may contribute to the prevalence and severity of allergies in the US. Let’s explore the reasons why allergies might feel more severe in the US and how they compare globally.

                                                                  WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                  Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions; including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. Additionally, the reconstituted single venom products are intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The Mixed Vespid venom protein is for immunotherapy only, not for diagnosis. Diagnosis should be based on individual venoms. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                  The Complex Landscape of Allergies in the US

                                                                  Allergies are caused by a immune system response to substances like pollen, pet dander, and certain foods. These responses can range from mild discomfort to severe, life-threatening reactions. While allergies are common globally, the factors influencing their prevalence and intensity vary. In the US, a combination of genetics, environmental conditions, and lifestyle factors creates a unique environment when it comes to allergies.

                                                                  Factors Affecting Allergy Prevalence and Severity

                                                                  Genetics and Population Diversity

                                                                  The genetic predisposition to allergies is unique in the US due to its diverse population. This means that a wide range of allergic reactions and the severity of those reactions can be observed across multiple ethnicities which are influenced by genetic differences.2,3,4 Research also suggests that individuals with a family history of allergies are more likely to experience them.5 The diverse genetic makeup of the US population, combined with other factors, creates a variety of allergy triggers and allergy responses.
                                                                  Woman suffering from allergies inside of an office.

                                                                  Environmental Triggers and Urbanization

                                                                  The US is home to a variety of environments, from lush forests and farmlands to sprawling urban centers. Urbanization often contributes to higher levels of air pollution which can exacerbate allergies.6

                                                                  Additionally, regional differences play a role in allergy severity and allergy type. Every region has allergies, but the triggers vary based on the environment, rather than the population. The only difference found between regions is that children in southern states aged one to five years old are more prone to allergies than their peers in other regions. The states with higher prevalence for young childhood allergies include: Texas, Oklahoma, Louisiana, Arkansas, Tennessee, Kentucky, Mississippi, Alabama, Georgia, West Virginia, Virginia, North Carolina, South Carolina, and Florida.7

                                                                  Climate Change

                                                                  One of the most significant drivers of increasing allergy prevalence in the US is climate change. Rising temperatures extend pollen seasons which leads to higher pollen production. Ragweed, a notorious allergen, thrives under these conditions. Studies have shown that allergy seasons in the US have extended by 20 days or more in certain areas, intensifying allergy symptoms for millions of Americans.

                                                                  How Do Allergy Rates in the US Compare Globally?

                                                                  When comparing the US to other countries, certain allergies appear to be more common than in other countries. These include:

                                                                  • Hay fever: The US has a higher prevalence for hay fever compared to other countries, likely due to differences in climate and vegetation.
                                                                  • Food allergies: Peanut allergies are notably more common in the US, possibly due to early exposure patterns and dietary habits.8

                                                                  In contrast, countries in Asia often report lower rates of hay fever but higher rates of skin allergies, although this is changing along with the climate.9 These variations are influenced by genetics, diet, and environmental conditions.

                                                                  Trends Over Time

                                                                  Allergies in the US have been on the rise over the past few decades. Along with the effects of climate change, the possible reasons for this include:

                                                                  • Hygiene hypothesis: The idea that cleaner environments reduce exposure to microbes, leading to an overactive immune system.10
                                                                  • Lifestyle changes: Sendentary lifestyles and processed diets may impact immune health, making people more susceptible to allergies.
                                                                  • Indoor air quality: Americans spend a significant amount of time indoors, where allergens like dust mites, mold, and pet dander thrive. Poor ventilation in modern buildings exacerbates these issues, creating an environment ripe for allergic reactions.12
                                                                  • Healthcare access and diagnosis rates: The US healthcare system plays a dual role. On one hand, advanced diagnostic tools and treatments are widely available, leading to earlier and more frequent diagnoses. On the other hand, the high cost of healthcare can limit access for many, leaving alelrgic conditions untreated.13
                                                                  Image of fields and polluting agents that effect allergies and asthma.

                                                                  So, Are Allergies Worse in the US?

                                                                  The answer isn’t straightforward. Allergies in the US are influenced by a mix of genetic diversity, environmental factors, and societal behaviors that make them feel more severe or widespread. While the US faces unique challenges like high pollen counts and climate-driven changes, it also benefits from advanced healthcare, such as allergy immunotherapy.

                                                                  Understanding the complexities of allergies is the first step towards better management. At HollisterStier Allergy, we are committed to elevating allergy care to empower allergists and ultimately benefit their patients. Request a quote today to see how we are supporting allergists and their patients here in the US.

                                                                  Article References

                                                                  1. Chalabi, Mona. “The Unlucky People Who Are More Likely to Have Seasonal Allergies.” The Cut, 28 June 2016, www.thecut.com/2016/06/the-unlucky-people-who-are-more-likely-to-have-seasonal-allergies.html. Accessed 19 Nov. 2024. 
                                                                  2. Wegienka, Ganesa, et al. “Racial Differences in Allergic Sensitization: Recent Findings and Future Directions.” Current Allergy and Asthma Reports, vol. 13, no. 3, 26 Feb. 2013, pp. 255–261, https://doi.org/10.1007/s11882-013-0343-2. Accessed 17 Sept. 2019. 
                                                                  3. Yang, James J., et al. “Differences in Allergic Sensitization by Self-Reported Race and Genetic Ancestry.” Journal of Allergy and Clinical Immunology, vol. 122, no. 4, Oct. 2008, pp. 820-827.e9, https://doi.org/10.1016/j.jaci.2008.07.044. Accessed 16 Apr. 2023. 
                                                                  4. Jiang, Jialing, et al. “Racial, Ethnic, and Socioeconomic Differences in Food Allergies in the US.” JAMA Network Open, vol. 6, no. 6, 14 June 2023, p. e2318162, jamanetwork.com/journals/jamanetworkopen/fullarticle/2806015?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=061423, https://doi.org/10.1001/jamanetworkopen.2023.18162. 
                                                                  5. Portelli, M. A., et al. “Genetic Risk Factors for the Development of Allergic Disease Identified by Genome-Wide Association.” Clinical & Experimental Allergy, vol. 45, no. 1, 26 Dec. 2014, pp. 21–31, https://doi.org/10.1111/cea.12327. Accessed 5 June 2019. 
                                                                  6. Gisler, Amanda. “Allergies in Urban Areas on the Rise: The Combined Effect of Air Pollution and Pollen.” International Journal of Public Health, vol. 66, 4 May 2021, https://doi.org/10.3389/ijph.2021.1604022. Accessed 7 Dec. 2021. 
                                                                  7. “Prevalence of Allergies the Same, regardless of Where You Live.” National Institutes of Health (NIH), 10 July 2015, www.nih.gov/news-events/news-releases/prevalence-allergies-same-regardless-where-you-live. Accessed 21 Nov. 2024. 
                                                                  8. Wilkin, David Anderson, Rebecca. “Why so Many Americans Are Allergic to Peanuts.” Business Insider, www.businessinsider.com/america-high-rate-peanut-allergies-compared-countries-2018-10. 
                                                                  9. Xing, Yuhan, and Gary Wing-Kin Wong. “Environmental Influences and Allergic Diseases in the Asia-Pacific Region: What Will Happen in next 30 Years?” Allergy, Asthma & Immunology Research, vol. 14, no. 1, 2022, p. 21, https://doi.org/10.4168/aair.2022.14.1.21. 
                                                                  10. Okada, H., et al. “The “Hygiene Hypothesis” for Autoimmune and Allergic Diseases: An Update.” Clinical & Experimental Immunology, vol. 160, no. 1, 11 Mar. 2010, pp. 1–9, www.ncbi.nlm.nih.gov/pmc/articles/PMC2841828/, https://doi.org/10.1111/j.1365-2249.2010.04139.x. 
                                                                  11. Zhang, Ping. “The Role of Diet and Nutrition in Allergic Diseases.” Nutrients, vol. 15, no. 17, 22 Aug. 2023, pp. 3683–3683, https://doi.org/10.3390/nu15173683. 
                                                                  12. Rosário Filho, Nelson Augusto, et al. “Air Pollution and Indoor Settings.” World Allergy Organization Journal, vol. 14, no. 1, Jan. 2021, p. 100499, www.worldallergyorganizationjournal.org/action/showPdf?pii=S1939-4551%2820%2930402-6, https://doi.org/10.1016/j.waojou.2020.100499. 
                                                                  13. Pappalardo, Andrea A. et al., “Health care access in allergy and immunology: Problems and potential solutions”, Journal of Allergy and Clinical Immunology, Volume 153, Issue 2, 401 – 403

                                                                  Photo of the HS Allergy Team

                                                                  SPOKANE, WA. – Jubilant HollisterStier Allergy is pleased to announce that it has received zero observations following a recent inspection conducted by the United States Food and Drug Administration, Center for Biologics Evaluation and Research (CBER). This success underscores Jubilant HollisterStier Allergy’s commitment to delivering high-efficacy, safe, and quality allergy extracts and allergenic products in accordance with rigorous industry standards.

                                                                  The completion of this inspection with no observations is a testament to Jubilant HollisterStier Allergy’s focus on compliance and quality assurance on their mission to elevate allergy. Jubilant HollisterStier Allergy will continue to set a high bar for excellence in allergy immunotherapy, supporting both healthcare providers and the communities they serve.

                                                                  “Receiving zero observations from CBER is a testament to the diligence and expertise of our team,” said Jerad Holcomb, Vice President of Quality. “We are committed to adhering to the most stringent quality standards, and this reflects in our collective dedication to operational excellence and patient safety.”

                                                                  “This achievement not only demonstrates Jubilant HollisterStier Allergy’s leadership in quality and compliance, but also reinforces the trust that healthcare providers and their patients have in our capabilities,” said Ben VanGerpen, Chief Scientific Officer. “Our teams are dedicated to continous improvement to meet the evolving regulatory requirements and maintain the highest standards of excellence.”

                                                                  This achievement reinforces Jubilant HollisterStier Allergy’s role as a trusted partner in the allergy care community.

                                                                  About Jubilant HollisterStier Allergy:

                                                                  Jubilant HollisterStier Allergy, a division of Jubilant Pharmova, has been a leading force in the allergenic extract industry for over 100 years. Jubilant HollisterStier Allergy is dedicated to innovation and serving the needs of healthcare providers and patients in the allergy industry.

                                                                  Venom Immunotherapy

                                                                  The immune system is the body’s first line of defense, protecting us from infections, pathogens, and harmful invaders. However, sometimes the immune system overreacts or reacts inappropriately to harmless substances, such as allergens like pollen, dust, dander, or venom, which results in an allergic reaction. Shifts and changes in the immune system causes by genetic factors, environmental influences, and certain conditions can predispose someone to a potential allergic response that they may not have experienced previously.

                                                                  WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                  Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions; including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. Additionally, the reconstituted single venom products are intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The Mixed Vespid venom protein is for immunotherapy only, not for diagnosis. Diagnosis should be based on individual venoms. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                  Understanding the Immune System and Allergies

                                                                  What is a Normal Immune Response?

                                                                  At its core, the immune system is designed to identify and neutralize harmful antigens such as bacteria, viruses, and fungi. It consists of various components, including white blood cells, antibodies, and a complex system of organs and proteins. When the immune system encounters a pathogen, they respond to try and eliminate the threat. The normal immune response is what keeps the body healthy and maintains homeostasis.1

                                                                  What Are Allergies?

                                                                  Allergies occur when the immune system mistakenly identifies a typically harmless substance, like allergens, as a threat. The immune response involves the release of chemicals like histamine, leading to symptoms like itching, swelling sneezing, and more severe reactions like anaphylaxis. Simplistically, allergies are a case of the immune system being “overprotective”.

                                                                  Immune System Changes and Their Effect on Allergies

                                                                  1. Genetic Factors

                                                                  Genetic predisposition plays a role in determining whether someone is likely to develop allergies during their lifetime. This genetic predisposition, known as atopy, can result in a variety of allergic responses, from sneezing to anaphylaxis.2 Families with a history of allergies tend to pass that on and those with a family history of allergies are more prone to having an overreactive immune system. There are a variety of genes that people can inherit from their parents that end up causing allergies in the future.3 Some of these gene mutations inherited within families may cause the immune system to produce more Immunoglobulin E (IgE), a key antibody involved in allergic reactions.4
                                                                  Woman suffering from allergies inside of an office.

                                                                  2. Environmental Factors

                                                                  Environmental factors play an equally significant role in allergy development. The “hygiene hypothesis” suggests that living in overly clean environments can prevent the immune system from being exposed to a wide range of bacteria and viruses early in life. This lack of exposure may shift the immune system towards a more allergic (Th2) response, as it hasn’t learned to differentiate between harmful and harmless invaders.5

                                                                  Pollution, urbanization, and climate change have also been linked to rising allergy rates, as they can affect how the immune system interacts with common allergens. For example, people living in urban areas may be exposed to higher levels of airborne pollutants, which can prime the immune system for allergic reactions. Similarly, climate change is causing longer pollen seasons and higher pollen counts, increasing exposure to allergens like grass and tree pollen.

                                                                  3. Age and Immune Changes

                                                                  Allergies can manifest at any age, though they are more common to manifest in childhood. The immune system is still developing when in childhood, making children more susceptible to overreacting to allergens. However, adults and even the elderly can develop new allergies due to shifts in their immune systems. Age-related changes in immune function, often referred to as immunosenescence, can make older individuals more susceptible to allergies as the immune system becomes less effective in distinguishing between harmful and harmless stimuli.7

                                                                  Immunodeficiencies and Allergies

                                                                  Weakened Immune System

                                                                  Certain conditions that weaken the immune system, such as HIV/AIDS, cancer, or the use of immunosuppressive medications for autoimmune diseases or after an organ transplant, can alter the body’s ability to process allergens. When the immune system is compromised, it may lose its ability to correctly identify allergens as harmless or put the immune system in overdrive, leading to an increase in allergic reactions. Immunodeficiency diseases result in an inability to fight off infections, but they may also cause the immune system to misfire, triggering allergies in individuals who might not have had them otherwise.8

                                                                  Autoimmune Disorders

                                                                  Autoimmune disorders, such as lupus or rheumatoid arthritis, occur when the immune system begins to attack the body’s own cells. People with autoimmune conditions may also experience allergies due to the heightened sensitivity of their immune response. In these cases, the immune system is already in a hyperactive state, making it more likely to overreact to external stimuli like allergens.

                                                                  Image of fields and polluting agents that effect allergies and asthma.

                                                                  Allergy Development: Th1/Th2 Balance

                                                                  The balance between two types of immune responses, Th1 (T-helper 1) and Th2 (T-helper 2), is an important part of the development of allergies. Th1 responses are typically protective against infections and pathogens, while Th2 resonses are involved in allergic reactions. In a healthy immune system, there is a balance between Th1 and Th2. However, when the Th2 response becomes dominant, the immune system is more likely to overreact to allergens.

                                                                  This imbalance is linked to early childhood environments. According to the hygiene hypothesis, reduced exposure to infections in childhood can lead to an underdeveloped Th1 response and an overreactive Th2 resposne. This imbalance makes children more susceptible to developing allergies as they grow older.5,9

                                                                  Managing Immune System Changes to Prevent or Treat Allergies

                                                                  Allergy Immunotherapy

                                                                  Allergy immunotherapy is a treatment method that involves gradually exposing individuals to small amounts of an allergen over time to desensitize the immune system. This process reduces the severity of allergic reactions by training the immune system to recognize allergens as harmless. HollisterStier Allergy provides a variety of extracts to conduct allergy immunotherapy treatments in the clinical setting.

                                                                  Diet and Lifestyle

                                                                  Diet and lifestyle also play a role in modulating the immune system’s response to allergens. A healthy gut microbiome, influenced by diet, is essential for maintaining immune balance. A diverse microbiome helps the immune system distinguish between what is harmful and what is not, potentially reducing the likelihood of allergic reactions.10

                                                                  Regular exercise, stress management, and avoiding smoking or excessive alcohol consumption can also support a balanced immune response. Conversely, a diet high in processed foods or exposure to chronic stress can exacerbate immune dysfunction and contribute to the development of allergies.

                                                                  The immune system is a complex network that protects us from harm, but it’s not always perfect. Changes in the immune system, whether due to genetics, environmental factors, or health conditions, can tip the scales toward developing or experiencing allergies. Understanding the intricate relationship between immune shifts and allergies can empower people to manage and potentially prevent allergic reactions through treatments like immunotherapy.

                                                                  Article References

                                                                  1. Information, National Center for Biotechnology, et al. How Does the Immune System Work? Www.ncbi.nlm.nih.gov, Institute for Quality and Efficiency in Health Care (IQWiG), 23 Apr. 2020, www.ncbi.nlm.nih.gov/books/NBK279364/#:~:text=The%20immune%20system%20has%20a. 
                                                                  2. Falcon, Robbi, and Salvador Caoili. “Immunologic, Genetic, and Ecological Interplay of Factors Involved in Allergic Diseases.” Frontiers in Allergy, 2 Aug. 2023, www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2023.1215616/full.
                                                                  3. Halloway, John, et al. “Genetics of Allergic Disease.” JACI Online, The Journal of Allergy and Clinical Immunology, Feb. 2010, www.jacionline.org/article/S0091-6749(09)01742-4/fulltext. 
                                                                  4. Altin, John, et al. “Understanding the Genetic Regulation of IgE Production.” Sciencedirect.com, Blood Reviews, 2010, www.sciencedirect.com/science/article/abs/pii/S0268960X10000251#:~:text=Abnormalities%20in%20the%20IL%2D6,in%20IgE%20production%20is%20elusive. 
                                                                  5. Okada, H., et al. “The “Hygiene Hypothesis” for Autoimmune and Allergic Diseases: An Update.” Clinical & Experimental Immunology, vol. 160, no. 1, 11 Mar. 2010, pp. 1–9, www.ncbi.nlm.nih.gov/pmc/articles/PMC2841828/, https://doi.org/10.1111/j.1365-2249.2010.04139.x. 
                                                                  6. D’Amato, Gennaro, et al. “Meteorological Conditions, Climate Change, New Emerging Factors, and Asthma and Related Allergic Disorders. A Statement of the World Allergy Organization.” World Allergy Organization Journal, vol. 8, 2015, p. 25, https://doi.org/10.1186/s40413-015-0073-0.
                                                                  7. Lee, Kyoo-A, et al. “Immune Senescence, Immunosenescence and Aging.” Frontiers in Aging, vol. 3, 30 May 2022, p. 900028, www.ncbi.nlm.nih.gov/pmc/articles/PMC9261375/, https://doi.org/10.3389/fragi.2022.900028. 
                                                                  8. AkdisMübeccel, et al. “Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-Specific T Regulatory 1 and T Helper 2 Cells.” Journal of Experimental Medicine, vol. 199, no. 11, 1 June 2004, pp. 1567–1575, https://doi.org/10.1084/jem.20032058. 
                                                                  9.  Romagnani, Sergio. “Immunologic Influences on Allergy and the TH1/TH2 Balance.” Journal of Allergy and Clinical Immunology, vol. 113, no. 3, Mar. 2004, pp. 395–400, https://doi.org/10.1016/j.jaci.2003.11.025. 
                                                                  10. Wiertsema, Selma P., et al. “The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.” Nutrients, vol. 13, no. 3, 9 Mar. 2021, p. 886, www.ncbi.nlm.nih.gov/pmc/articles/PMC8001875/, https://doi.org/10.3390/nu13030886. 

                                                                            Venom Immunotherapy

                                                                            Allergies of all kinds disrupt the lives of individuals worldwide and range in symptoms from mild discomfort to severe reactions. For those suffering from chronic and potentially life-threatening allergies, finding long-term relief can be challenging. While antihistamines and other medications may provide temporary relief, they don’t address the root cause which results in an allergic reaction. This is why allergy immunotherapy is a game-changer in the treatment of allergies – it is the only treatment that not only alleviates symptoms, but also alters the way the immune system responds to allergens. 5

                                                                            Allergy immunotherapy, which includes both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), is a method of treatment that gradually desensitizes the immune system to specific allergens. Over time, this leads to a significant reduction or even complete elimination of allergic reactivity. (HollisterStier products have not been authorized by the FDA for SLIT route of administration. Please refer to the full prescribing information for HollisterStier products.)

                                                                            WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                            Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions; including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. Additionally, the reconstituted single venom products are intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The Mixed Vespid venom protein is for immunotherapy only, not for diagnosis. Diagnosis should be based on individual venoms. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                            Allergy Basics

                                                                            To understand how allergy immunotherapy works, it’s essential to grasp what allergies are and how they affect the body. Allergies occur when the immune system mistakenly identifies a harmless substance such as pollen, dust mites or pet dander, as a threat. In response, the immune system produces antibodies called Immunoglobulin E (IgE), which trigger the release of histamines and other biological chemicals, leading to the symptoms associated with allergies: sneezing, itching, swelling, and more.

                                                                            Allergic reactions can vary in severity, ranging from mild seasonal allergies to life-threatening anaphylaxis. Common allergens include:

                                                                            • Pollen
                                                                            • Mold spores
                                                                            • Pet dander
                                                                            • Insect stings
                                                                            • Certain foods (nuts, shellfish, dairy, etc.)

                                                                            Alleriges can significantly impact quality of life, making daily activities uncomfortable or even dangerous for those with severe reactions.

                                                                            What is Allergy Immunotherapy?

                                                                            Allergy immunotherapy is along-term treatment designed to reduce sensitivity to allergens. Unlike medications that mask symptoms, immunotherapy addresses the underlying immune response, teaching the body to tolerate allergens rather than overreact to them.

                                                                            The concept of allergy immunotherapy dates back to the early 20th  century when Leonard Noon and John Freeman discovered that hay fever was caused by a sensitivity to grass pollen and that by introducing the same pollen in a distilled extract, patients would experience less severe symptoms. Today, immunotherapy is a well-established treatment used worldwide to manage a variety of allergies.1

                                                                            There are two main types of allergy immunotherapy: SCIT, commonly known as allergy shots, and SLIT, which involves placing drops or tablets under the tongue. Both methods aim to achieve the same goal, reducing the immune system’s overreaction to allergens, although they differ in their administration and treatment duration.

                                                                            Woman suffering from allergies inside of an office.

                                                                            How Allergy Immunotherapy Works

                                                                            Allergy immunotherapy works by gradually exposing the immune system to increasing amounts of the allergen is allergic to, helping the body build tolerance over time. The treatment typically follows two phases5:

                                                                            1. Desensitization (Build-Up) Phase: During this initial phase, the patient receives small doses of the allergen through a specific extract solution, either through injections or sublingual drops or tablets. These doses are gradually increased over several weeks or months, allowing the immune system to adapt without triggering a severe allergic reaction. The goal is to “train” the immune system to recognize the allergen as “harmless” so that an immune reaction is not triggered.
                                                                            2. Maintenance Phase: Once the optimal dose is reached, the patient enters the maintenance phase, where the allergen extract dose remains consistent. By repeatedly exposing the body to the allergen, immunotherapy reduces the production of IgE antibodies and promotes the production of other antibodies, such as Immunoglobulin G (IcG), which block the allergen before it triggers an allergic response. Over time, this reprogramming of the immune system can lead to long-term tolerance, even after the treatment is ended.

                                                                            Types of Allergy Immunotherapy

                                                                            As mentioned previously, there are two types of allergy immunotherapy, each with its unique approach and benefits:

                                                                            • Subcutaneous Immunotherapy (SCIT):
                                                                              • Description and procedure: SCIT is the most common form of immunotherapy. It involves injecting small amounts of the allergen into the skin, usually in the upper arm. The injections start with a low dose and gradually increase over time.
                                                                              • Frequency and duration: SCIT typically requires weekly or bi-weekly visits to the allergist during the build-up phase, which lasts about 3-6 months. Once the maintenance dose is reached, injections are spaced out every 2-4 weeks for 3-5 years.
                                                                              • Benefits and potential side effects: SCIT is highly effective for a wide range of allergens including pollen, dust mites, and insect stings. Side effects are generally mild and may include redness or swelling at the injection site. Rarely, more severe reactions like anaphylaxis can occur, so treatments must be administered in a medical setting by a trained medical professional.
                                                                            • Sublingual Immunotherapy (SLIT)*:
                                                                              • Description and procedure: SLIT involves placing allergen drops or tablets under the tongue, where the allergen is taken up by the immune system.
                                                                              • Frequency and duration: SLIT requires daily administration, which can be done at home.  Like SCIT, the treatment typically lasts 3-5 and must be prescribed by a medical provider.
                                                                              • Benefits and potential side effects: SLIT is a convenient option for those who prefer not to undergo regular injections or who might not have access to a medical provider every week. Side effects may include mild itching or swelling in the mouth. Serious reactions are rare, so certain patients may be advised to carry an epinephrine auto-injector as a precaution.

                                                                            Comparing SCIT and SLIT:

                                                                            Both SCIT and SLIT are effective at reducing allergy symptoms and improving quality of life. The choice between the two depends on factors such as the type of allergy, patient preference, and convenience. SCIT is more versatile and treats a broader range of allergens. SCIT is currently the only effective treatment option for stinging insect venom allergies, including bee, wasp, yellowjacket, and hornet venom. The main benefit of SLIT is the lower likelihood of severe reactions which allows the treatment to be administered at home, reducing the amount of time a patient needs to spend in a medical office.

                                                                            Effectiveness and Benefits of Allergy Immunotherapy

                                                                            Allergy immunotherapy has been extensively studied and proven effective in reducing allergy symptoms and improving overall quality of life. Allergy immunotherapy can lead to long-lasting benefits, even after treatment ends. Patients often experience a significant reduction in the need for allergy medications and a decrease in the frequency and severity of symptoms.

                                                                            One of the key benefits of immunotherapy is its potential to prevent the development of new allergies and asthma. Studies have shown that children treated with allergy immunotherapy may be less likely to develop asthma later in life.5

                                                                            Image of fields and polluting agents that effect allergies and asthma.

                                                                            Who Can Benefit from allergy Immunotherapy?

                                                                            Allergy immunotherapy is suitable for many patients. Ideal candidates include:

                                                                            • Patients with moderate to severe allergies that are not well controlled with symptomatic medications
                                                                            • Patients allergic to unavoidable allergens
                                                                            • Patients known to have an anaphylactic reaction to an allergen in the past
                                                                            • Patients older than five years old (or able to comply with treatment instructions and communicate any possible reactions)

                                                                            Immunotherapy may not be suitable for patients with certain medical conditions, such as severe asthma or immune system disorders. A thorough evaluation by an allergist is essential to determine if immunotherapy is the right option.

                                                                            Allergy immunotherapy offers a promising solution for those seeking long-term relief from allergies. By gradually desensitizing the immune system to specific allergens, immunotherapy reduces symptoms and addresses the root cause of the allergy. Whether administered through injections or sublingual drops6, immunotherapy can notably improve quality of life for allergy sufferers. With the potential to modify the course of allergic diseases and provide lasting relief, immunotherapy is a powerful tool in the fight against allergic reactions.

                                                                             

                                                                            *HollisterStier products have not been authorized by the FDA for SLIT route of administration. Please refer to the full prescribing information for HollisterStier products.

                                                                            Article References

                                                                            1. “Hay Fever: Allergen-Specific Immunotherapy (Desensitization) in the Treatment of Allergies.” Nih.gov, Institute for Quality and Efficiency in Health Care (IQWiG), 13 July 2017, www.ncbi.nlm.nih.gov/books/NBK279487/. 
                                                                            2. “Allergies: Overview.” Nih.gov, Institute for Quality and Efficiency in Health Care (IQWiG), 13 July 2017, www.ncbi.nlm.nih.gov/books/NBK447112/.  
                                                                            3. McLendon, Kevin, and Britni T Sternard. “Anaphylaxis.” National Library of Medicine, StatPearls Publishing, 26 Jan. 2023, www.ncbi.nlm.nih.gov/books/NBK482124/.  
                                                                            4. Schworer, Stephen A, and Edwin H Kim. “Sublingual Immunotherapy for Food Allergy and Its Future Directions.” Immunotherapy, vol. 12, no. 12, Aug. 2020, pp. 921–931, https://doi.org/10.2217/imt-2020-0123. 
                                                                            5. Memon, Ruba J., et al. “Allergy Desensitization.” PubMed, StatPearls Publishing, 2020, www.ncbi.nlm.nih.gov/books/NBK535367/. 
                                                                            6. Saporta, Diego. “Efficacy of Sublingual Immunotherapy versus Subcutaneous Injection Immunotherapy in Allergic Patients.” Journal of Environmental and Public Health, vol. 2012, 2012, pp. 1–6, www.ncbi.nlm.nih.gov/pmc/articles/PMC3317104/, https://doi.org/10.1155/2012/492405.
                                                                            7. Cox, Linda, et al. “Allergen immunotherapy: a practice parameter third update.”Journal of Allergy and Clinical Immunology127.1 (2011): S1-S55.  https://www.jacionline.org/article/S0091-6749(10)01503-4/fulltext 

                                                                                        Venom Immunotherapy

                                                                                        Dust mite allergies are a common allergy affecting approximately 20 million people across the United States with 84% of households in the U.S. having the presence of dust mites.1 These tiny, invisible pests thrive in our homes, especially in areas where dust accumulates, and can trigger allergy reactions that significantly impact quality of life. This article explores what dust mites are, how they cause allergy symptoms, common symptoms, and effective ways to manage and mitigate dust mite allergies.

                                                                                        WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                                        Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions; including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. Additionally, the reconstituted single venom products are intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The Mixed Vespid venom protein is for immunotherapy only, not for diagnosis. Diagnosis should be based on individual venoms. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                                        What Are Dust Mites?

                                                                                        Dust mites are microscopic indoor insects that thrive in items like pillows, mattresses, box springs, bedding, rugs and carpets, upholstered furniture, and stuffed toys. Dust mites feed on organic matter like human skin cells, pet dander, pollen, fungi, and bacteria. They thrive in humid, warm environments which makes homes an ideal habitat for them.

                                                                                        How Do Dust Mites Cause Allergies?

                                                                                        Dust mite allergies are caused by an enzyme found in the hard shell of their bodies and in their feces. When these particles become airborne, they can be inhaled, triggering an allergic reaction in sensitized individuals. The immune system identifies these enzyme particles as harmful invaders, leading to the release of histamines and other chemicals that result in an allergic reaction with varying symptoms.
                                                                                        Woman suffering from allergies inside of an office.

                                                                                        Common Symptoms of Dust Mite Allergies

                                                                                        When people experience dust mite alelrgies, they may have hay-fever-like symptoms while others may have breathing difficulties. Symptoms of dust mite allergies can range from mild to severe and often include1:

                                                                                         

                                                                                        • Sneezing
                                                                                        • Rhinorrhea
                                                                                        • Allergic conjunctivitis
                                                                                        • Nasal stuffiness
                                                                                        • Itchy skin, nose, mouth, or throat
                                                                                        • Postnasal drip
                                                                                        • Cough
                                                                                        • Lethargy or general malaise
                                                                                        • Impaired sleep caused by shortness of breath, coughing, or wheezing
                                                                                        There are some factors that predispose someone to develop dust mite allergies, including1:

                                                                                         

                                                                                        • A family history of allergies
                                                                                        • Reactiveness in childhood or adolescence
                                                                                        • Exposure to a high level of dust mites

                                                                                        Diagnosing Dust Mite Allergies

                                                                                        There are multiple ways that an allergist can test a patient for a potential dust mite allergy. Primarily, allergists will conduct a skin prick test as the first line of testing as it has a high sensitivity and is convenient while yielding results within 20 minutes.1 In a skin prick test, a small amount of the allergen extract is applied to the skin using a testing device like HollisterStier Allergy’s Comforten® skin testing system, and the area is then observed for a reaction.

                                                                                        Managing Dust Mite Allergies

                                                                                        While it is impossible to completely eliminate dust  mites from the home, there are several strategies that can be employed to reduce their presence and manage potential allergy symptoms:

                                                                                         

                                                                                        • Maintain cleanliness: Regularly clean the home to reduce dust accumulation. Use a damp cloth to wipe surfaces and a vacuum cleaner with a HEPA filter to trap dust mites and their waste.
                                                                                        • Control humidity: Keep indoor humidity levels below 50% using dehumidifiers and air conditioners. Dust mites thrive in humid environments, so reducing humidity can significantly decrease their population.
                                                                                        • Use allergen-proof bedding: Encase mattresses, pillows, and box springs in allergen-proof covers to prevent dust mites from infiltrating the sleeping area. Wash bedding in hot water at a minimum of 130º weekly to kill dust mites.
                                                                                        • Reduce clutter: Minimize the number of items that collect dust and store items in plastic containers to keep dust at bay.
                                                                                        • Choose hard flooring: Carpets can harbor large amounts of dust mites. Consider buying or replacing carpets with hard flooring which is easier to clean.
                                                                                        • Use HEPA filters: Install HEPA filters in the home’s heating and cooling systems to trap dust mites and other allergens from the air.
                                                                                        • Medications and treatments: Over-the-counter antihistamines, decongestants, and nasal corticosteroids can help manage symptoms. In more severe cases, allergists can recommend allergy immunotherapy to gradually desensitize the immune system to dust mites. HollisterStier Allergy offers a multitude of extracts for allergy immunotherapy treatment, including standardized dust mite extracts.
                                                                                        Image of fields and polluting agents that effect allergies and asthma.
                                                                                        Dust mite allergies can be challenging to manage, but with the right strategies, awareness, and treatments, people can significantly reduce exposure and alleviate symptoms. For more information on managing allergies and the latest in allergy treatments, visit HollisterStier Allergy’s available extracts page or contact our team of highly trained sales representatives.

                                                                                        Article References

                                                                                        1Aggarwal, Pearl, and S. Senthilkumaran. “Dust Mite Allergy.” PubMed, StatPearls Publishing, 2021, www.ncbi.nlm.nih.gov/books/NBK560718/.
                                                                                        2“Dust Mite Allergy.” Asthma & Allergy Foundation of America, aafa.org/allergies/types-of-allergies/insect-allergy/dust-mite-allergy/. 

                                                                                        Venom Immunotherapy is a life-changing treatment for individuals who are severely allergic to stinging insects such as bees, wasps, and hornets. This therapy is vital in helping patients manage and overcome their fears of potentially life-threatening allergic reactions.  

                                                                                        In this article, we interview Marc Thomas, a Medical Science Liaison at HollisterStier Allergy and a professional healthcare provider in ENT allergy since 1989. Marc oversaw the allergy department for S.E.O.O. Inc. for twenty-three years, and then moved on to work with Antigen Laboratories where he eventually became Antigen’s Clinical Science Liaison before moving on to HollisterStier. In this interview, Marc delves into the intricacies of venom immunotherapy. Marc shares personal insights, explains how venom immunotherapy works, and highlights its profound impact on patients’ lives. 

                                                                                        Disclaimer – Marc Thomas is a paid consultant and not an employee of HollisterStier. The thoughts and opinions are his own and reflect his personal experience in the field of allergy.

                                                                                        WARNING Important Safety Information (See full prescribing information for complete boxed warning.)

                                                                                        Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions; including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. Additionally, the reconstituted single venom products are intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. The Mixed Vespid venom protein is for immunotherapy only, not for diagnosis. Diagnosis should be based on individual venoms. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

                                                                                        Interview on Venom Immunotherapy

                                                                                        What is venom immunotherapy and how does it work?

                                                                                        “Venom immunotherapy essentially is a process in which medical providers can test people to first determine whether patients are at risk of having a truly life-threatening situation with venom. I did this for 20 years in my practice, and many patients aren’t clear where they stand when it comes to bee sting reactions.  

                                                                                        Some of them know which stinging insects cause their allergy, some of them don’t. But even if they do, often they’re not clear whether their situation is potentially life-threatening. Sometimes just clarifying that, by being tested, can be helpful. Testing is done using blood tests, preferably skin tests, and we can determine if a person is sensitive. 

                                                                                        Once that is determined, then of course we try to convince them to embark upon immunotherapy because it’s really the only thing that can retrain the body not to react so violently to venom. As a matter of fact, 75-98% of people that go through immunotherapy for venom will not have a systemic reaction or have a reaction that is milder than before going through treatment.1 There are not many therapies in medicine that can give patients and physicians a high amount of confidence in personal safety, but venom immunotherapy is one of them.” 

                                                                                        Graphed image of the various venom immunotherapy species used in treatment extracts.

                                                                                        What do patients need to know before starting venom immunotherapy?

                                                                                        “A lot of patients need to know, number one, are they sensitive enough to experience a severe reaction if they get stung. Number two, if they are severely allergic, then we need to try to encourage them to pursue immunotherapy. Venom immunotherapy is the process of taking the venom of the insect that they’re sensitive to and giving them small doses of it over time, gradually getting their immune system used to it, retraining it until they can get to a point where they can tolerate a full sting with no reaction.” 

                                                                                        Is there an example or success story that you have with venom immunotherapy?

                                                                                        “I had a lot of patients over the years that sent me follow-up mail and cards essentially saying that VIT gave them their lives back. When people are in this kind of situation, they’re afraid to go to family gatherings outside, weddings, or graduations. I had one patient whose parents bought her a convertible for her college graduation. She got stung while out driving her car and made it to the emergency room, but almost succumbed to the sting and fell through the door getting in there. She was scared to drive with her top-down, scared to be outside at all, but after going through venom immunotherapy, she was stung again, and nothing happened. It essentially gave her life back and modeled to other people that they could have their lives back too. It showed that it’s really a successful program.” 

                                                                                        What do you think are some trepidations that discourage medical professionals from providing venom immunotherapy?

                                                                                        Graphed image of the various venom immunotherapy species used in treatment extracts.
                                                                                        “A lot of nurses and staff are afraid of it; they relate the idea of “venom” to “poison” and get scared that people are going to react more violently to it than other allergy extracts you might use. When I first started, I’ll admit I was afraid to do it. Initially, I was afraid I was going to do someone harm, because that’s the last thing that any prudent nurse wants to have happen. But after I provided treatment for a while, I found I was quite comfortable with it and found it even more comfortable treating a venom sensitive patient than a mold allergic asthmatic, because sometimes that’s even trickier. 

                                                                                        It’s similar to how, for years, we called and spoke about the strengths of allergy extracts as potency. But over time, a lot of us who have been in the industry for a long time switched away from saying potent to saying biologically active. This is because the word potency there again is another one of those words that implies poison or danger in somebody’s mind. 

                                                                                        Certainly, we need people to know that in handling venom, if they go about it without following proper instructions, it can be harmful and dangerous. But in the right hands and handled properly, it is a safe procedure, and most people get through it well. It has good outcomes and, if nothing else, just being able to live without being in fear that you’re going to get stung and experience a severe reaction.” 

                                                                                        What makes VIT different from non-standardized extracts when it comes to diagnosis and treatment?

                                                                                        “Although all extract treatments go through rigorous research and testing, VIT stands out because we understand that the venom allergy proteins are the cause of the allergy, so we know exactly what we’re delivering to patients. We know exactly what proteins are involved in the reaction and so we know exactly what we’re delivering and exactly how much we’re delivering. Whereas a lot of the non-standardized extracts like mold and pollens, even some animal danders, we don’t know exactly what the allergen components in some of those treatments are and we don’t know exactly what the right doses are for each individual person when it comes to their treatment.

                                                                                        What do you think is important for patients to know or understand about venom immunotherapy?

                                                                                        Graphed image of the various venom immunotherapy species used in treatment extracts.
                                                                                        “There’s a disconnect sometimes between the emergency room patients that are being seen in the ER for a life-threatening reaction who’ve had shots of adrenaline to deter that severe reaction. Often the ER tells patients that they should try to avoid stinging insects and that they should get an epinephrine pen and carry that with them. This creates a misconception by the public that if they’ve got an epinephrine pen, that’s going to save them, but it may not.  

                                                                                        I’ve always compared the rapidity of the reaction the patients have to a venom sting to that of a car crash and I compare the seat belt or airbags to the epinephrine pen or medications that you might use. If you’re travelling down the road at 150 miles an hour and you crash into a bridge there’s probably not too much of a likelihood that your seat belt or airbag or any of that’s going to save you. But if you can slow that car down to 50 miles an hour, and you hit that bridge, then your seat belt or airbag will probably save you. 

                                                                                        If nothing else, even if we can’t build a person up to where they can tolerate a full sting, we can build their tolerance up enough to where it slows the reaction down and buys time for the medications to work or for them to get to where they can get more care. 

                                                                                        We’re saving lives. Patients need to understand VIT and that it is very effective. If we can get them on this treatment, it can be life-changing for patients. If nothing else, if we can slow down the reaction, we can buy them time. You can’t put a dollar sign on that.” 

                                                                                        Marc Thomas

                                                                                        Marc Thomas

                                                                                        Medical Science Liaison, HollisterStier Allergy

                                                                                        Marc Thomas has been a registered nurse for forty-eight years. After his graduation from nursing school, he worked in an emergency room in Zanesville, OH, and then in the offices of Southeastern Ohio Otolaryngology, where he developed their allergy department, all the while mentoring with many of the pioneers in the field of ENT allergy. He worked in the ER in the evenings, while managing the allergy department through the day clinically and from the business side. By 1989, he was only working occasionally in the ER and his focus was entirely on the field of allergy. Marc continued to attend courses sponsored by the American Academy of Otolaryngic Allergy as well as the Pan American Allergy Society, the American Academy of Environmental Medicine, the American Academy of Asthma, Allergy, and Immunology, and the American College of Allergy, Asthma, and Immunology. After overseeing the allergy department for S.E.O.O. Inc. for twenty-three years, where they offered inhalant allergy testing, food testing, chemical testing, as well as insect allergy testing and treatment for their patients, he went on to work with Antigen Laboratories, an FDA licensed allergy extract manufacturer. After an initial time in sales, as the Midwest Regional Manager, he became Antigen’s Clinical Science Liaison and continued in that capacity until their merger with Greer in 2013. The merger of Antigen Labs with Greer was orchestrated by Aeres Life Sciences. He has helped set up and train many offices around the country since 1980 and he continues to work as an Independent Allergy Nurse Consultant with forty-five years dedicated to allergy. Most of his time is currently spent assisting the customers of Jubilant HollisterStier Allergy. He is well versed in all aspects of allergy from the clinical perspective and the regulatory and business side of the field. His knowledge continues to be sought by physicians and other companies throughout the country.

                                                                                        Article References

                                                                                        1 Golden, D. B. (2007). Insect Sting Anaphylaxis. Immunology and Allergy Clinics of North America, 27(2), 261-272. doi:10.1016/j.iac.2007.03.008

                                                                                        Venom Immunotherapy
                                                                                        Seasonal allergies affect millions of people worldwide, and due to a variety of factors, allergy season is becoming more severe and prolonged. Seasonal allergies have begun to extend past the spring into summer, fall, and even early winter in certain areas due to climate change. The main drivers behind this increase are longer growing seasons for plants and agriculture, along with higher levels of carbon dioxide (CO2) that then enhance plant growth and pollen production.1 As the planet continues to transform due to climate change brought on by industry, the expectation is that respiratory health will be negatively impacted while exacerbating conditions such as allergies and asthma.2

                                                                                        The rise in the severity of allergy seasons is linked to a complex system of factors that are based in environmental changes, mostly through human interference. According to D’Amato, Gennaro, et al., increased concentrations of greenhouse gases have warmed the planet substantially since the industrial revolution, causing prolonged heat waves, changes in temperature, increased air pollution, and increased amounts of natural disasters, all of which impact the respiratory health of people. For those who suffer from allergies and asthma, these changes are especially difficult to live with, and it’s crucial to understand the implications of these changes on allergy sufferers and what proactive measures can be taken to help mitigate complications.

                                                                                        Understanding Allergy Seasons

                                                                                        Woman suffering from allergies inside of an office.

                                                                                        Overview of Common Allergens

                                                                                        Allergens are substances that cause an allergic reaction, whether it be localized or systematic, and can be found throughout people’s daily environment. Some of the most common allergens include8: 

                                                                                         

                                                                                        • Pollen 
                                                                                        • Dust mites 
                                                                                        • Pets and/or farm animals 
                                                                                        • Stinging insect venom 
                                                                                        • Foods 
                                                                                        • Medication 
                                                                                        • Contact allergens, such as metals or fragrance 
                                                                                        • Mold 

                                                                                        Factors Contributing to the Worsening of Allergy Seasons

                                                                                        The increasing severity of allergy seasons, specifically those of pollen allergens, can be attributed to several key factors2: 

                                                                                        • Climate change 
                                                                                        • Air pollution 
                                                                                        • Globalization and migration 

                                                                                        The Effects of Climate Change & Air Pollution

                                                                                        There is a large body of evidence that demonstrates that the temperature of the Earth is rising substantially, which is confirmed through higher ocean temperatures, rising sea levels, glacier melt, and the shrinking of sea ice in the North and South Poles, along with less snow cover in the Northern Hemisphere during winter months.2 

                                                                                        Climate change has a direct impact on allergies and asthma sufferers as these temperature changes affect the length of both growth and pollen seasons for plants and influences mold production. There is also a solid link between climate change, industrialization, and air pollution, which has shown an increase in pollution-related episodes of rhinitis and asthma.2 

                                                                                        According to Williams, Riis, climate change alters pollen patterns within the United States because it lengthens the amount of time during what’s called the “frost-free” season, which is when plants can produce blossoms and sprouts without the risk of frost damage. Since the beginning of the 20th century, the frost-free season has increased by more than two weeks on average and has increased by an average of at least 11 days in the nine distinct climate regions of the U.S. Therefore, pollen production has both increased and pollen season is extended, resulting in more people with pollen allergies having more and longer allergic symptoms. 

                                                                                        Image of fields and polluting agents that effect allergies and asthma.

                                                                                        What to Expect Going Forward

                                                                                        Longer Duration of Allergy Seasons

                                                                                        As mentioned above, the duration of allergy seasons has increased since the start of the industrial revolution. In a 2015 study published by PubMed, the pollen season started on average three days earlier between 2001 and 2010 in the U.S. compared to the 1990’s. The amount of airborne pollen also increased by approximately 40% during this time.5 

                                                                                        Higher Pollen Counts & Increased Allergen Levels

                                                                                        As climate change leads to longer and more intense pollen seasons, trees are releasing more pollen earlier and for a longer amount of time. The allergenicity of this tree pollen also appears to be stronger compared to past pollen seasons, resulting in more symptoms for allergy sufferers.6 This increase in the allergenic response then results in more people going to the doctor or emergency room, putting a higher burden on healthcare systems as people experience reactions and more susceptibility for other infections as their immune system is overloaded.

                                                                                        Worst Cities for Allergies

                                                                                        According to the Asthma and Allergy Foundation of America, there are certain cities in the U.S. that are particularly challenging for allergy sufferers due to high pollen levels, widespread allergen exposure, and limited access to allergy specialists. The top 20 cities of 2024 include: 

                                                                                         

                                                                                        1. Wichita, Kansas 
                                                                                        2. Virginia Beach, VA 
                                                                                        3. Greenville, SC 
                                                                                        4. Dallas, TX 
                                                                                        5. Oklahoma City, OK 
                                                                                        6. Tulsa, OK 
                                                                                        7. Richmond, VA 
                                                                                        8. Des Moines, IA 
                                                                                        9. Raleigh, NC 
                                                                                        10. Fayetteville, AR 
                                                                                        11. Allentown, PA 
                                                                                        12. Baton Rouge, LA 
                                                                                        13. Sarasota, FL 
                                                                                        14. Houston, TX 
                                                                                        15. Columbia, SC 
                                                                                        16. Orlando, FL 
                                                                                        17. Little Rock, AR 
                                                                                        18. Chattanooga, TN 
                                                                                        19. Greensboro, NC 
                                                                                        20. Kansas City, MO 

                                                                                        How to Prepare for the Future

                                                                                        Monitoring Pollen Counts & Air Quality Indexes

                                                                                        Keeping track of pollen counts and air quality indexes is essential when it comes to managing allergies and tracking the severity of allergy seasons. According the Asthma and Allergy Foundation of America, pollen counts are taken from samples of pollen gathered at monitoring sites and are based off actual data, while pollen forecasts. Reliable sources for pollen information include pollen forecasts and counts from the National Allergy Bureau (NAB), which is affiliated with the American Academy of Allergy, Asthma, & Immunology (AAAAI)There are also pollen activity calendars available on our website that outlines which pollens are most prominent by region and time of year. 

                                                                                        Tips for Reducing Allergen Exposure at Home and Outdoors

                                                                                        Tips for at home prevention: 

                                                                                        • Use high-efficiency particulate air (HEPA) filters in the home 
                                                                                        • Keep windows closed during high-pollen days 
                                                                                        • Regularly clean the home to minimize dust mites, mold spores, and pet dander 
                                                                                        • Maintain low humidity levels to prevent mold growth 

                                                                                        Tips for outdoor prevention: 

                                                                                        • Avoid outdoor activities during peak pollen time by monitoring pollen counts and forecasts 
                                                                                        • Wear protective wear such as sunglasses, face masks, or long clothing to protect from potential allergen exposure 
                                                                                        • Shower and change clothes after spending time outdoors to remove pollen from the body 

                                                                                        Overview of Available Allergy Medications and Treatments

                                                                                        Several medications and treatments are available to alleviate allergy symptoms: 

                                                                                        • Antihistamines 
                                                                                        • Decongestants 
                                                                                        • Nasal Corticosteroids 
                                                                                        • Leukotriene Receptor Antagonists 
                                                                                        • Allergy Immunotherapy, which HollisterStier Allergy provides for various allergens and stinging insect venom 

                                                                                        It is essential to understand the factors driving changes in allergy seasons and severity of symptoms so that proactive measures can be taken to mitigate allergic responses. Although some aspects are out of personal control, there are ways for healthcare professionals to inform and advocate for their patients now and in the future. 

                                                                                        Article References

                                                                                        1Schmidt, Charles W. “Pollen Overload: Seasonal Allergies in a Changing Climate.” Environmental Health Perspectives, vol. 124, no. 4, Apr. 2016, https://doi.org/10.1289/ehp.124-a70.

                                                                                        2D’Amato, Gennaro, et al. “Meteorological Conditions, Climate Change, New Emerging Factors, and Asthma and Related Allergic Disorders. A Statement of the World Allergy Organization.” World Allergy Organization Journal, vol. 8, 2015, p. 25, https://doi.org/10.1186/s40413-015-0073-0. 

                                                                                        3“Allergies: Overview.” Nih.gov, Institute for Quality and Efficiency in Health Care (IQWiG), 13 July 2017, www.ncbi.nlm.nih.gov/books/NBK447112/.

                                                                                        4Williams, Riis. “Seasonal Allergies May Be Getting Worse because of Climate Change.” Scientific American,.

                                                                                        5Zhang, Yong, et al. “Allergenic Pollen Season Variations in the Past Two Decades under Changing Climate in the United States.” Global Change Biology, vol. 21, no. 4, 7 Nov. 2014, pp. 1581–1589, https://doi.org/10.1111/gcb.12755. Accessed 3 Oct. 2021.

                                                                                        6Asthma and Allergy Foundation of America, (2024). 2024 Allergy Capitals. Retrieved from allergycapitals.com. 

                                                                                        7“AAAAI.” Pollen.aaaai.org, pollen.aaaai.org/#/.